Bank QNB Indonesia Tbk vs Tempo Scan Pacific Tbk. — how do they compare? Bank QNB Indonesia Tbk trades at Rp51 (market cap 1.78T, 3.06M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,500 (market cap 11.36T, 200K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 6.4× Bank QNB Indonesia Tbk's market cap, and Bank QNB Indonesia Tbk is more actively traded (3.06M versus 200K). Which is the better fit depends on your goals.
| BKSW | TSPC | |
|---|---|---|
Market Cap | 1.78T | 11.36T |
Volume | 3.06M | 200K |
Lot | 30.63K | 2K |
Turnover | 154.08M | 500.06M |
Average Price | 50.3 | 2,500.28 |
Value | 154.08M | 500.06M |
Indicative Equilibrium Price | 51 | 2,500 |
Indicative Equilibrium Volume | 10 | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bank QNB Indonesia Tbk (the Bank) was established on April 1, 1913 under the name of N.V Chunghwa Shangyeh Maatschappij (The Chinese Trading Company Limited) based on the Notarial Deed No. 53 dated April 28,.1913 of Notary Leonard Hendrik-Willem Van Sandick and was approved based on Besluit Gouverneur Generaal Hindia Belanda No. 58 dated July 16, 1913 and was published in the Extra Bijvougsel der Javasche Courant No. 78 dated September 30, 1913. The Bank's name was changed into PT BankKesawan based on the Deed of Articles of Association Amendment No. 60 dated March 10, .1965 of Ong Kiem Lian, SH, notary public in Jakarta. Subsequently, following the acquisition of the Bank's shares by Qatar National Bank S.A.Q. on January 26,.2011, the Bank‟s name was changed into PT Bank QNB Kesawan Tbk. Subsequently, the bank's name was changed into PT. Bank QNB Indonesia Tbk.
Read more on BKSW →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →